1Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med,2010,363: 1107-1116.
2CRASH-2 trial collaborators, Shakur H, Roberts I, et al. Effeets of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage ( CRASH-2 ) : a randomised, placebo-controlled trial. Lancet, 2010, 376:23 -32.
3de Smet AM, Kluytmans JA, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU Patients. N Engl J Mcd, 2009,360:20-3 I.
4Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical- site infections in nasal carriers of Staphylococcus aureus. N Engl J Med ,2010,362:9-17.
5Bouadma L, Luyt CE,Tubach F, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units ( PRORATA trial) : a muhicentre randomised controlled trial. Lancet, 2010,375 : 463 -474.
6Strcm T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation:a randomised trial. Lancet,2010,375:475-480.
7Levy MM,Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign:results of an international guideline-based peribrmance improvement program targeting severe sepsis. Crit Care Med,2010, 38: 367-374.
8Barochia AV,Cui X,Vitberg D,et al. Bundled care for septic shock: an analysis of clinical trials. Crit Care Med,2010,38:668-678.
9Field JM, Hazinski MF, Sayre MR, et al. Part 1 :executive summary: 2010 American Heart Association Guidelines for Cardiopuhnonary Resuscitation and Emergency Cardiovascular Care. Circulation, 2010,122 ( Suppl 3 ) : $640-$656.
10Kim MM, Bamato AE, Angus DC, et al. The effect of muhidisciplinary care teams on intensive care unit mortality. Arch Intern Med,2010,170:369-376.
